Artificial intelligence (AI) can predict the presence of molecular alterations directly from
routine histopathology slides. However, training robust AI systems requires large datasets for …

Although it has long been known that the immune cell composition has a strong prognostic
and predictive value in colorectal cancer (CRC), scoring systems such as the immunoscore (…

INTRODUCTION: Immune checkpoint inhibitors (ICI) have been approved for patients with
clear cell renal cell carcinoma (ccRCC), but not all patients benefit from ICI. One reason is the …

… Financial disclosures: Sebastian Foersch certifies that all conflicts of interest, including
specific financial interests and relationships and affiliations relevant to the subject matter or …

BACKGROUND & AIMS: Epidermal growth factor receptor (EGFR) is a therapeutic target for
colorectal cancer (CRC). However, technical challenges have limited in vivo imaging of …

Precision oncology relies on the identification of targetable molecular alterations in tumor
tissues. In many tumor types, a limited set of molecular tests is currently part of standard …

Growing evidence proposes an important role for pro-inflammatory cytokines during tumor
development. Several experimental and clinical studies have linked the pleiotropic cytokine …

Background Vascular endothelial growth factor (VEGF) is a therapeutic target in gastrointestinal
cancer (GiC). However, its in vivo visualisation could not be achieved to date with …

Deep learning (DL) can accelerate the prediction of prognostic biomarkers from routine
pathology slides in colorectal cancer (CRC). However, current approaches rely on convolutional …

Deep learning (DL) can predict microsatellite instability (MSI) from routine histopathology
slides of colorectal cancer (CRC). However, it is unclear whether DL can also predict other …